Lymphedema Treatments
Find Lymphedema Treatments
Brand Name
Panretin
Generic Name
Alitretinoin
View Brand Information FDA approval date: September 10, 2019
Classification: Retinoid
Form: Gel
What is Panretin (Alitretinoin)?
Panretin ® gel is indicated for topical treatment of cutaneous lesions in patients with AIDS-related Kaposi’s sarcoma. Panretin ® gel is not indicated when systemic anti-KS therapy is required . There is no experience to date using Panretin ® gel with systemic anti-KS treatment.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment